Jeevan Scientific Technology Limited (BOM:538837)
84.36
+0.47 (0.56%)
At close: May 27, 2026
BOM:538837 Revenue
Jeevan Scientific Technology had revenue of 190.72M INR in the quarter ending December 31, 2025, with 52.48% growth. This brings the company's revenue in the last twelve months to 503.08M, up 5.13% year-over-year. In the fiscal year ending March 31, 2025, Jeevan Scientific Technology had annual revenue of 468.44M with 18.14% growth.
Revenue (ttm)
503.08M
Revenue Growth
+5.13%
P/S Ratio
2.66
Revenue / Employee
1.91M
Employees
263
Market Cap
1.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 468.44M | 71.93M | 18.14% |
| Mar 31, 2024 | 396.51M | 34.73M | 9.60% |
| Mar 31, 2023 | 361.78M | -323.55M | -47.21% |
| Mar 31, 2022 | 685.33M | 210.50M | 44.33% |
| Mar 31, 2021 | 474.83M | 225.84M | 90.70% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 1, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BSL Limited | 6.58B |
| Bal Pharma | 3.09B |
| Cubex Tubings | 2.88B |
| Kaira Can Company | 2.42B |
| Vibrant Global Capital | 1.84B |
| Sampann Utpadan India | 1.43B |
| Sanco Trans | 1.32B |
| Swastika Investmart | 1.01B |